Hosted on MSN9mon
Why Is ARCA Biopharma (ABIO) Stock Up 85% Today?
Clinical-stage biopharmaceutical firm ARCA Biopharma (NASDAQ:ABIO) — which develops and commercializes cardiovascular disease therapies — saw its shares skyrocket during the midweek session.
U.S. News & World Report3y
9 Short Squeeze Stocks That Could Take Off
Earn $+0.06 per options contract and 5.1% APY on cash with no restrictions. Arca biopharma is a clinical-stage biopharmaceutical company that specializes in developing targeted therapies for ...